Search Results for "Parasitic"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Parasitic. Results 11 to 20 of 34 total matches.
Mefloquine for Malaria
The Medical Letter on Drugs and Therapeutics • Feb 09, 1990 (Issue 811)
strains; the higher doses cleared
the parasites from the blood more rapidly and led to earlier resolution ...
Mefloquine hydrochloride (Lariam - Roche), a new antimalarial drug chemically related to quinine, has been approved by the US Food and Drug Administration (FDA) for prevention and treatment of Plasmodium falciparum and P. vivax malaria.
Health Problems in the Persian Gulf
The Medical Letter on Drugs and Therapeutics • Feb 22, 1991 (Issue 838)
hemorrhagic fever,
malaria, and various other parasitic infections.
THE MEDICAL LETTER (ISSN 1523-2859 ...
With the deployment of hundreds of thousands of troops in Saudi Arabia, health problems endemic to the Arabian Peninsula may be coming to the attention of physicians in the USA and other areas.
In Brief: Alternatives to Mifepristone for Medication Abortion
The Medical Letter on Drugs and Therapeutics • Jun 26, 2023 (Issue 1679)
parasitic infections.
DRUGS FOR HEAD LICE — Since most available
pediculicides are not ovicidal ...
The possibility that use of mifepristone (Mifeprex,
and generics) may be restricted has led to questions
about alternatives for medication abortion.
Med Lett Drugs Ther. 2023 Jun 26;65(1679):102-3 doi:10.58347/tml.2023.1679d | Show Introduction Hide Introduction
Insect Repellents
The Medical Letter on Drugs and Therapeutics • Jul 12, 2021 (Issue 1628)
, dengue, West Nile, eastern
equine encephalitis, and yellow fever viruses, and the
malaria parasite ...
The Centers for Disease Control and Prevention
(CDC) and the Environmental Protection Agency
(EPA) recommend using insect repellents to prevent
infections transmitted by mosquitoes and ticks.
Insect repellents applied to exposed skin should be
used in conjunction with other preventive measures
such as wearing pants and long-sleeved shirts and
avoiding outdoor activities during peak mosquito-biting
times. Mosquitoes can transmit diseasecausing
pathogens, including Zika, chikungunya,
dengue, West Nile, eastern equine encephalitis, and
yellow fever viruses, and the malaria parasite....
In Brief: OTC Ivermectin for Head Lice
The Medical Letter on Drugs and Therapeutics • Jun 26, 2023 (Issue 1679)
. It binds to glutamategated
chloride channels in parasites such as lice,
inducing paralysis and death ...
Topical ivermectin lotion 0.5% (Sklice, and generics),
which has been available by prescription since 2012,
is now FDA-approved for sale over the counter (OTC)
for treatment of head lice in patients ≥6 months old.
Ivermectin is also available by prescription as a 1%
cream (Soolantra) approved for topical treatment of
inflammatory lesions of rosacea and in oral tablets
(Stromectol, and generics) for treatment of various
parasitic infections.
Med Lett Drugs Ther. 2023 Jun 26;65(1679):103-4 doi:10.58347/tml.2023.1679e | Show Introduction Hide Introduction
Levamisole With Fluorouracil For Colon Cancer
The Medical Letter on Drugs and Therapeutics • Oct 06, 1989 (Issue 802)
).
ACTIVITY — Levamisole stimulates ganglionic structures and inhibits fumarate reductase in
some parasites ...
Levamisole (Janssen), an old antiparasitic drug widely used for treatment of ascariasis in animals, is now available from the National Cancer Institute (NCI) for investigational use with fluorouracil (5-FU; Adrucil; and others) as an adjuvant for treatment of resectable colon cancer that has metastasized to regional lymph nodes (Dukes stage C).
In Brief: IV Artesunate for Severe Malaria
The Medical Letter on Drugs and Therapeutics • May 19, 2008 (Issue 1286)
falciparum malaria: a randomised trial. Lancet 2005;
366:717.
2. Drugs for parasitic infections. New ...
The drug of choice for patients who require parenteral treatment for malaria is IV artesunate, which is available now from the CDC Malaria Branch (M-F, 8 AM-4:30 PM eastern time, 770-488-7788 or, after hours, 770-488-7100). Artesunate appears to be more effective than quinine1 and safer than quinidine, the other parenteral alternatives in the US. The CDC has supplies of artesunate in Atlanta and in 8 quarantine stations in major airports around the US. It will release the drug for appropriate patients (severe disease or unable to take oral drugs) if it can be supplied as quickly as quinidine,...
COVID-19 Update: NIH Recommends Against Ivermectin
The Medical Letter on Drugs and Therapeutics • Jun 13, 2022 (Issue 1652)
by parasitic
organisms such as Strongyloides stercoralis and
Onchocerca volvulus. In vitro, high ...
On April 29, the NIH recommended against use of the antiparasitic drug ivermectin for treatment of COVID-19 outside of a clinical trial. The recommendation was made because recent randomized, placebo-controlled trials of ivermectin have produced negative results and because alternative drugs that have been shown to be effective for treatment of COVID-19 are available.
Ivermectin (Sklice) Topical Lotion for Head Lice
The Medical Letter on Drugs and Therapeutics • Aug 06, 2012 (Issue 1396)
, inducing
paralysis and death in the parasites. Ivermectin lotion
0.5% is not directly ovicidal ...
The FDA has approved the antiparasitic drug ivermectin
in a 0.5% lotion (Sklice – Sanofi Pasteur) as a
single-use topical treatment for head lice in patients ≥6
months old. Oral ivermectin (Stromectol – Merck) is
effective for treatment of head lice resistant to other
therapies, but it has not been approved by the FDA for
this indication.
Delayed-Release Budesonide (Tarpeyo) for Primary Immunoglobulin A Nephropathy
The Medical Letter on Drugs and Therapeutics • May 16, 2022 (Issue 1650)
,
bacterial, systemic viral or parasitic infections, or
ocular herpes simplex.
The Medical Letter ® Vol. 64 ...
The FDA has approved Tarpeyo (Calliditas), a delayed-release
capsule formulation of the corticosteroid
budesonide, to reduce proteinuria in adults with
primary immunoglobulin A nephropathy (IgAN; also
called Berger's disease) who are at risk of rapid
disease progression. It is the fi rst drug to be approved
in the US for this indication. Oral formulations
of budesonide have been available for years for
treatment of inflammatory bowel disease.